Ana Polanco, Market Access and Corporate Affairs director at Merck Spain, has been voted president of the Spanish Bioindustry Association (Asebio) for the upcoming two-year term, taking over from Jordi Martí. The members voted on 18 December at the association’s general assembly.
Also voted in were Vice-presidents Belén Barreiro, general director of Ingenasa; Elena Pérez, CEO of A4Cell; and Javier Terriente, CSO of ZeClinics. The voting members of the board of directors are Rocío Arroyo of Amadix, Nora Alonso of Iden Biotechnology, Carmen Eibe of Pharma Mar, Antonio López of Science & Innovation Link Office, and Gurutz Linazasoro of Vive Biotech.
Comments